Evidence map›Paper›PMID 40568131›Full record

ArticlebioRxiv : the preprint server for biology2025

Functional relevance of CASP16 nucleic acid predictions as evaluated by structure providers.

Rachael C Kretsch, Reinhard Albrecht, Ebbe S Andersen, Hsuan-Ai Chen, Wah Chiu, Rhiju Das, Jeanine G Gezelle, Marcus D Hartmann, Claudia Höbartner, Yimin Hu and 23 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

33 authors.

Rachael C KretschBiophysics Program, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-6935-518X
Reinhard AlbrechtDepartment of Protein Evolution, Max Planck Institute for Biology Tübingen, Max-Planck-Ring 5, 72076 Tübingen, Germany.
Ebbe S AndersenDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-6236-8164
Hsuan-Ai ChenInstitute of Organic Chemistry and Center for Nanosystems Chemistry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID 0000-0002-0586-0742
Wah ChiuBiophysics Program, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0002-8910-3078
Rhiju DasBiophysics Program, Stanford University School of Medicine, Stanford, California, USA.ORCID 0000-0001-7497-0972
Jeanine G GezelleDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.ORCID 0000-0003-3664-6199
Marcus D HartmannDepartment of Protein Evolution, Max Planck Institute for Biology Tübingen, Max-Planck-Ring 5, 72076 Tübingen, Germany.ORCID 0000-0001-6937-5677
Claudia HöbartnerInstitute of Organic Chemistry and Center for Nanosystems Chemistry, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.ORCID 0000-0002-4548-2299
Yimin HuDepartment of Protein Evolution, Max Planck Institute for Biology Tübingen, Max-Planck-Ring 5, 72076 Tübingen, Germany.ORCID 0000-0002-6965-8965
Shekhar JadhavEuropean Molecular Biology Laboratory (EMBL) Grenoble, 71 Avenue des Martyrs, Grenoble 38042, France.ORCID 0009-0009-4682-7568
Philip E JohnsonDepartment of Chemistry, York University, Toronto, Ontario M3J 1P3, Canada.ORCID 0000-0002-5573-4891
Christopher P JonesBiochemistry and Biophysics Center, National Heart, Lung and Blood Institute, Bethesda, MD, USA.ORCID 0000-0001-7780-5278
Deepak KoiralaDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County; Baltimore, MD, USA.ORCID 0000-0001-6424-3173
Emil L KristoffersenDepartment of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-8965-8201
Eric LargyUniv. Bordeaux, Inserm U1212, CNRS UMR 5320, ARNA, F-33000 Bordeaux, France.ORCID 0000-0002-6140-9788
Anna LewickaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-9578-2628
Cameron D MackerethUniv. Bordeaux, Inserm U1212, CNRS UMR 5320, ARNA, F-33000 Bordeaux, France.ORCID 0000-0002-0776-7947
Marco MarciaEuropean Molecular Biology Laboratory (EMBL) Grenoble, 71 Avenue des Martyrs, Grenoble 38042, France.ORCID 0000-0003-2430-0713
Michela NigroEuropean Molecular Biology Laboratory (EMBL) Grenoble, 71 Avenue des Martyrs, Grenoble 38042, France.ORCID 0000-0003-1847-475X
Manju OjhaDepartment of Chemistry and Biochemistry, University of Maryland Baltimore County; Baltimore, MD, USA.ORCID 0009-0001-3907-431X
Joseph A PiccirilliDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-0541-6270
Phoebe A RiceDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-3467-341X
Heewhan ShinDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9656-6639
Anna-Lena SteckelbergDepartment of Biochemistry and Molecular Biophysics, Columbia University, New York, NY, USA.ORCID 0000-0001-7988-9946
Zhaoming SuThe State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-9279-1721
Yoshita SrivastavaDepartment of Biochemistry and Molecular Biology, The University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9091-9851
Liu WangThe State Key Laboratory of Biotherapy, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-1243-9654
Yuan WuHoward Hughes Medical Institute, Stanford University, CA USA.ORCID 0009-0000-6122-2457
Jiahao XieMingle Scope (Chengdu), 138 2nd Tianfu Street, Chengdu, 610096, China.ORCID 0000-0002-4632-2959
Nikolaj H ZwergiusInterdisciplinary Nanoscience Center (iNANO), Aarhus University, Aarhus, Denmark.ORCID 0009-0007-4155-2468
John MoultDepartment of Cell Biology and Molecular Genetics, Institute for Bioscience and Biotechnology Research, University of Maryland, Rockville, MD, USA.ORCID 0000-0002-3012-2282
Andriy KryshtafovychGenome Center, University of California, Davis, CA, USA.ORCID 0000-0001-5066-7178

Funding

The Stanford-SLAC CryoEM Center supplementU24GM129541 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH, HEDMAN, BRITT · 2018 to 2023
$54.8M
User Training and OutreachP30GM124165 · NIGMS · CORNELL UNIVERSITY · PI STEVEN E EALICK · 2018 to 2026
$34.2M
Center for Structural Biology of HIV RNAU54AI170660 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALICE TELESNITSKY · 2022 to 2026
$32.1M
Unified Data Resource for Large Complexes Determined by Cryo-Electron MicroscopyR01GM079429 · NIGMS · STANFORD UNIVERSITY · PI CHIU, WAH · 2007 to 2021
$11.6M
Prospective analysis to determine model accuracy performance and boundaries in the post-AlphaFold2 environmentR01GM100482 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIDELIS, KRZYSZTOF A · 2012 to 2025
$11.1M
Next-generation computational/chemical methods for complex RNA structuresR35GM122579 · NIGMS · STANFORD UNIVERSITY · PI Rhiju Das · 2017 to 2026
$7.2M
Graduate Training at The Chemistry Biology InterfaceT32GM066706 · NIGMS · UNIVERSITY OF MARYLAND BALTIMORE COUNTY · PI SELEY-RADTKE, KATHERINE L, SMITH, AARON T · 2004 to 2023
$3.3M
Structure and Function of Non-Coding RNAR35GM149336 · NIGMS · UNIVERSITY OF CHICAGO · PI Joseph Anthony Piccirilli · 2023 to 2026
$2.8M
Pixel Array Detector for Macromolecular CrystallographyS10OD021527 · OD · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2016 to 2016
$2.0M
Understanding the antiviral roles of acellular RNA quality control pathwayR35GM150778 · NIGMS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Anna-Lena Steckelberg · 2023 to 2026
$1.6M
NIAID NIH HHS U54 AI170660NIGMS NIH HHS P30 GM124165NIGMS NIH HHS R01 GM079429NIGMS NIH HHS R01 GM100482NIGMS NIH HHS R35 GM122579NIGMS NIH HHS R35 GM149336NIGMS NIH HHS R35 GM150778NIGMS NIH HHS T32 GM066706NIGMS NIH HHS U24 GM129541NIH HHS S10 OD021527
6 · The paper itself

Abstract

Accurate biomolecular structure prediction enables the prediction of mutational effects, the speculation of function based on predicted structural homology, the analysis of ligand binding modes, experimental model building and many other applications. Such algorithms to predict essential functional and structural features remain out of reach for biomolecular. Here, we report quantitative and qualitative evaluation of nucleic acid structures for the CASP16 blind prediction challenge by 12 of the experimental groups who provided nucleic acid targets. Blind predictions accurately model secondary structure and some aspects of tertiary structure, including reasonable global folds for some complex RNAs, however, predictions often lack accuracy in the regions of highest functional importance. All models have inaccuracies in non-canonical regions where, e.g., the nucleic-acid backbone bends or a base forms a non-standard hydrogen bond. These bends and non-canonical interactions are integral to form functionally important regions such as RNA enzymatic active sites. Additionally, the modeling of conserved and functional interfaces between nucleic acids and ligands, proteins, or other nucleic acids remains poor. For some targets, the experimental structures may not represent the only structure the biomolecular complex occupies in solution or in its functional life-cycle, posing a future challenge for the community.

Identifiers

PMID40568131
PMCPMC12191101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.